LTRN vs SBAC · $35.1M cap vs P/E 30, rev $1.42B
Lantern Pharma Inc (LTRN) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
Lantern Pharma Inc (LTRN) is a biotechnology company listed on US.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
LTRN does not have a complete income-statement cache yet.
Latest reported SBAC revenue for 2026-06-30 was $1.42B. Net income was $383.6M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
LTRN currently screens at market cap $35.1M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the LTRN and SBAC stock pages for the full models.
Not investment advice.